Drugs in Dev.
Immunology
Preclinical
Lithuania 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IMP761
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Immutep
Deal Size : Undisclosed
Deal Type : Agreement
Immutep Advances IMP761 Manufacturing
Details : Under the agreement, Northway has already started developing a GMP-compliant manufacturing process of IMP761 and will manufacture IMP761 in large scale bioreactors. Planning for further pre-clinical and clinical development is ongoing.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
December 16, 2021
Lead Product(s) : IMP761
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Immutep
Deal Size : Undisclosed
Deal Type : Agreement
